| Product Description |
|
| Baby’s Jarro-Dophilus contains superior, scientifically documented strains. Clinical studies have documented the benefits of B. breve M-16V and B. longum BB536 (morinaga) in infants and young children. All probiotic strains in Baby’s Jarro-DophilusTM produce L+ lactic acid which is especially ideal for babies. The dominant intestinal flora of infants are the bifidobacteria which is why Baby’s Jarro-Dophilus contains a higher percentage of bifidobacteria than lactobacilli. Baby’s Jarro-Dophilus, a vegetarian formula, also contains Inulin-FOS (FructoOligoSaccharides) to encourage growth of beneficial flora.
|
| |
| Suggested Use |
|
| Up to age 4, mix 1/4 tsp. daily in water, juice,
infant formula or food, or as directed by your qualified health consultant. For newborns, mix into formula only 1/16 tsp per day for the first week. A small amount of powder may also be dabbed on mother’s nipple before breast feeding.
|
| |
| Ingredients/Supplement Facts |
|
| Supplement Facts |
Each 1/4 teaspoon contains: |
| Ingredients |
Amount |
%DV |
| Vitamin C |
4 mg |
10% |
| Inulin (source of FOS) |
973 mg |
† |
Probiotic Bacteria
Bifidobacterium breve M-16v = 25% 750 Million
Bifidobacterium infantis Bi-07 = 15% 450 Million
Bifidobacterium longum BB536 (Morinaga) = 15% 450 Million
Bifidobacterium bifidum Bb-02 = 15% 450 Million
Lactobacillus casei Lc-11 = 15% 450 Million
Lactobacillus rhamnosus Lr-32 = 15% 450 Million
Total = 100% 3 Billion |
3 Billion Organisms |
|
†: Daily value not established.
|
|
|
| |
| Warning! Read carefully before using Babys Jarro Dophilus |
|
Do not feed powder directly to infants.
Keep in refrigerator or freezer. Packaged by weight, not volume.
Keep out of the reach of children.
|
| |
| Disclaimer |
|
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, cure, mitigate, treat, or prevent any disease.
|
